Gene proriling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support

被引:80
|
作者
Birks, EJ
Hall, JL
Barton, PJR
Grindle, S
Latif, N
Hardy, JP
Rider, JE
Banner, NR
Khaghani, A
Miller, LW
Yacoub, MH [1 ]
机构
[1] Royal Brompton & Harefield Hosp, Heart Sci Ctr, Harefield UB9 6JH, Middx, England
[2] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Heart Sci Ctr, London SW7 2AZ, England
[3] Univ Minnesota, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA
关键词
heart failure; heart-assist device; myocardial contraction; remodeling; genes;
D O I
10.1161/CIRCULATIONAHA.104.526137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-After left ventricular-assist device (LVAD) support, a proportion of patients recover sufficient ventricular function to enable explantation of the device. The exact molecular mechanisms involved in myocardial recovery remain unknown. Cytoskeletal proteins are essential for the structure and function of the cardiac myocyte and might play a major role. Methods and Results-A total of 15 patients with nonischemic cardiomyopathy who required LVAD implantation were studied; 6 recovered sufficiently to allow explantation of the device compared with 9 who did not recover and required transplantation. LV myocardial samples were collected at implantation and explantation/transplantation. Affymetrix microarray analysis was performed on the paired samples and analyzed with reference to sarcomeric and nonsarcomeric cytoskeletal proteins. In the recovery group, of the nonsarcomeric proteins, lamin A/C increased 1.5-fold (P < 0.05) and spectrin 1.6-fold (P < 0.05) between the times of implantation and explantation. Integrins beta 1, beta 6, and alpha 7 decreased 1.7-fold (P < 0.05), 2.4-fold (P < 0.05), and 1.5-fold (P < 0.05), respectively, but integrins alpha 5 and beta 5 increased 2.3-fold (P < 0.01) and 1.2-fold (P < 0.01) at explantation. The following sarcomeric proteins changed in the recovered group only: beta-actin increased 1.4-fold (P < 0.05); a-tropomyosin, 1.3-fold (P < 0.05); alpha 1-actinin, 1.8-fold (P < 0.01); and alpha-filarnin A, 1.6-fold (P < 0.05). Both troponin T3 and alpha 2-actinin decreased by 1.6-fold at the time of explantation (P<0.05). Vinculin decreased 1.7-fold (P=0.001) in the recovered group but increased by 1.7-fold (P<0.05) in the nonrecovered group. Vinculin protein levels decreased 4.1-fold in the recovered group. Conclusions-Myocardial recovery was associated with a specific pattern of changes in sarcomeric, nonsarcomeric, and membrane-associated proteins, which could have important implications in understanding the mechanisms involved.
引用
收藏
页码:I57 / I64
页数:8
相关论文
共 50 条
  • [41] Cardiac Recovery in Patients with Adriamycin-Induced Cardiomyopathy After Left Ventricular Assist Device Support
    Coromilas, E. J.
    Garan, A. R.
    Yuzefpolskaya, M.
    Takeda, K.
    Takayama, H.
    Farr, M.
    Naka, Y.
    Colombo, P. C.
    Topkara, V. K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S269 - S270
  • [42] Comparison of Percutaneous and Surgical Right Ventricular Assist Device Support After Durable Left Ventricular Assist Device Insertion
    Coromilas, Ellie J.
    Takeda, Koji
    Ando, Masahiko
    Cevasco, Marisa
    Green, Phillip
    Karmpaliotis, Dimitri
    Kirtane, Ajay
    Topkara, Veli K.
    Yuzefpolskaya, Melana
    Takayama, Hiroo
    Naka, Yoshifumi
    Burkhoff, Daniel
    Colombo, Paolo C.
    Garan, A. Reshad
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (02) : 105 - 113
  • [43] Cardiac recovery during left ventricular assist device support: Results from the LVAD Working Group
    Maybaum, S
    Frazier, OH
    Starling, R
    Miller, L
    Murali, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 233A - 233A
  • [44] The Duration of Inotropic Support and Survival After Left Ventricular Assist Device
    Grandin, E.
    Mooney, D.
    Kennedy, K.
    Kiernan, M. S.
    Kociol, R. D.
    Teuteberg, J. J.
    Pagani, F. D.
    Gaffey, A. C.
    Atluri, P.
    Birati, E. Y.
    Myers, S.
    Naftel, D.
    Oliveira, G.
    Simpson, K. E.
    Yeh, R. W.
    Kirklin, J. K.
    Kormos, R. L.
    Rame, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S140 - S140
  • [45] Regression of cellular hypertrophy after left ventricular assist device support
    Zafeiridis, A
    Jeevanandam, V
    Houser, SR
    Margulies, KB
    CIRCULATION, 1998, 98 (07) : 656 - 662
  • [46] Expression of Extracellular Matrix Genes During Myocardial Recovery From Heart Failure After Left Ventricular Assist Device Support
    Felkin, Leanne E.
    Lara-Pezzi, Enrique
    George, Robert
    Yacoub, Magdi H.
    Birks, Emma J.
    Barton, Paul J. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : 117 - 122
  • [47] Papillary muscle rupture after myocardial infarction during left ventricular assist device support
    Kunioka, Shingo
    Kitahara, Hiroto
    Kanda, Hirotsugu
    Takeda, Tomohiro
    Yoshida, Yuri
    Ishikawa, Natsuya
    Kamiya, Hiroyuki
    JOURNAL OF ARTIFICIAL ORGANS, 2017, 20 (03) : 263 - 265
  • [48] Papillary muscle rupture after myocardial infarction during left ventricular assist device support
    Shingo Kunioka
    Hiroto Kitahara
    Hirotsugu Kanda
    Tomohiro Takeda
    Yuri Yoshida
    Natsuya Ishikawa
    Hiroyuki Kamiya
    Journal of Artificial Organs, 2017, 20 : 263 - 265
  • [49] Echocardiographic myocardial strain during left ventricular assist device support
    Noor, M. A. R.
    Haley, S. Rahman
    Bowles, C. T.
    Banner, N. R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1007 - 1007
  • [50] Electrical reverse remodeling during left ventricular assist device support
    Drakos, S.
    Anastasiou-Nana, M.
    Charitos, E.
    Ntalianis, A.
    Terrovitis, J.
    Tsagalou, E.
    Kaldara, E.
    Theodoropoulos, S.
    Yacoub, M.
    Nanas, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 143 - 143